Categories: Hospitals

Dr. A. Ramachandrans Diabetes Hospitals, No.110, Anna salai, Guindy, Chennai – 600032 INDIA, Landmark – Opposite to ITC Grand Chola

Hospital Name: Dr. A. Ramachandrans Diabetes Hospitals

Address: No.110, Anna salai, Guindy, Chennai – 600032 INDIA, Landmark – Opposite to ITC Grand Chola

Tel. No: +91 44 42162003, 04, +91 44 22353729, 30, 31, 32

Email id: ramachandran@ardiabetes.org

Website: http://www.ardiabetes.org/

Profile

Dr. A. Ramachandran, M.D.,Ph.D.,D.Sc.,FRCP.(Lond).(Edin)., an internationally acknowledged pivotal figure in the field of contemporary Diabetes Health Care and Research, has established Dr. A. Ramachandran’s Diabetes Hospitals (Dr.ARH) to provide state of the art tertiary care services in the management of diabetes mellitus and its complications. He has also established theIndia Diabetes Research Foundation to achieve the mission of collective action for sustained population wide improvement in diabetes health care in our country and other developing countries.

Dr. A. Ramachandran’s Diabetes Hospitals, an unit of Dr. Ramachandrans Diabetes care PVT Ltd., situated at Guindy and Egmore are multi speciality diabetes hospitals. They are centres of excellence for diabetes health care in India. The hospitals provide state of the art medical care in diabetes and its related specialities such as cardiology, neurology, podiatry, orthopedics, plastic and vascular surgery, nephrology with dialysis units, medical nutrition therapy, phychological counseling, modern amenities to conduct minor and major surgeries and fully equipped intensive care units to manage critically ill patients.

The Diabetes Care team includes Senior Consultant Diabetologists Prof. A. Ramachandran, Dr. Samith Shetty, Dr. Arun Raghavan, Dr. Nanditha Arun, Dr. Santhosh Jeyaraj, Dr. Uma Mahesh, Dr. Roopesh Jain & Dr. Bharati, Diabetes Periodontal surgeon Dr. Vinitha Ramachandran, Senior Biochemist by Dr. C. Snehalatha. Diabetes foot specialist Dr. Lakshmi and the Post Graduate Medical Education Dean Prof. K. Raghavan.

To improve the quality of diabetes health care provided in India and other developing countries, IDRF has been established with the following objectives:

1. To carry out basic and applied research in Diabetes.

2. To establish, provide, maintain and conduct or assist research laboratories and institutions for scientific research in Diabetes.

3. To disseminate the research findings by publications for the health care providers and lay public.

4. To train health care providers including doctors and other diabetes health care providers to improve the quality of diabetes health care in India and other developing countries.

5. To promote, develop and improve scientific exchange of knowledge as well as technical co-operation between similar research institutions.

6. To conduct conferences, refresher courses, lectures, seminars, demonstrations and exhibitions on diabetes health care.

7. To associate and collaborate with international and national research institutions, to promote diabetes research.

8. To provide, award, institute fellowship or scholarships, stipends, remuneration and/or other similar payments to students and research scholars to facilitate their undertaking scientific research in the areas of concerned interest to the Society.

9. To promote and participate in global and national diabetes health care initiatives.

10. To be an apex institution in providing evidence based solutions to the health policy makers and health administrators in formulating and implementing diabetes health care delivery systems.

The Pharma Times News Bureau

Recent Posts

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

18 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

18 hours ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

2 days ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

2 days ago

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

3 days ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

3 days ago